MedPath

Evaluation of the effect of omega-3 supplementation on lipid profile, insulin resistance, inflammatory parameters and SIRT1 in obese children and adolescents, a randmized placebo controlled clinical trial

Phase 2
Conditions
Obesity.
Obesity due to excess calories
Registration Number
IRCT201612014585N10
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

BMI above 95th percentile for the specific age and gender
healthy and not having any disease
not taking medications specially those that interfere with lipid and carbohydrate metabolism
Exclusion criteria:
BMI between 85th and 95th percentile
BMI lower than 5th percentile
taking medications
having any other disease other than obesity

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin resistance. Timepoint: 60 days. Method of measurement: HOMA-IR index.;Inflammatory markers. Timepoint: 60 days. Method of measurement: ELISA.;Sirtuin 1 gene expression. Timepoint: 60 days. Method of measurement: Real-time PCR.;Lipid profile. Timepoint: 60 days. Method of measurement: calorimetric.
Secondary Outcome Measures
NameTimeMethod
Body mass index. Timepoint: 60 days. Method of measurement: weight/height*height.
© Copyright 2025. All Rights Reserved by MedPath